United Therapeutics | UTHR - Fremdkapital

Aktienkurs
531.38
Täglich Wechseln
-8.64 -1.60%
Monatlich
10.58%
Jährlich
66.66%
Q1 Prognose
519.93




Fremdkapital Veränderung Datum
Ardelyx USD 202.14M 27.07M 2025-09
Baxter International USD 9.47B 726M 2025-12
Bayer EUR 31.83B 877M 2025-12
BioCryst Pharmaceuticals USD 428.67M 234.31M 2025-12
Biogen USD 6.29B 1.4M 2025-09
BioMarin Pharmaceutical USD 597.18M 513K 2025-12
Emergent BioSolutions USD 446.5M 1.7M 2023-12
Esperion Therapeutics USD 457.65M 9.5M 2025-12
Gilead Sciences USD 22.14B 5M 2025-09
GlaxoSmithKline GBP 14.71B 186M 2025-12
Halozyme Therapeutics USD 2.14B 1.34B 2025-12
Insmed USD 540.96M 1.24M 2025-12
Ionis Pharmaceuticals USD 1.9B 1.87B 2025-12
J&J USD 39.44B 30M 2025-12
Lexicon Pharmaceuticals USD 49.41M 7.1M 2025-12
Moderna USD 610M 584M 2025-12
Omeros USD 403.72M 27.2M 2024-06
Pfizer USD 57.41B 93M 2025-09
PTC Therapeutics USD 2.03B 193.22M 2025-12
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 828.97M 206.17M 2025-12
Teva Pharmaceutical Industries USD 14.99B 1.78B 2025-12
United Therapeutics USD 100M 100M 2024-06
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03